PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation

Por Hirai, T, Masaki, T, Kuratsune, M, Yorioka, N, Kohno, N
Publicado em 2006

Effect of different sensitizing doses of antigen in a murine model of atopic asthma

Por Sakai, K, Yokoyama, A, Kohno, N, Hiwada, K
Publicado em 1999

Interactions of doxorubicin and cis-platin in squamous carcinoma cells in culture.

Por Kohno, N., Ohnuma, T., Kaneko, M., Holland, J. F.
Publicado em 1988

Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of t...

Por Awaya, H, Takeshima, Y, Furonaka, O, Kohno, N, Inai, K
Publicado em 2005

p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung

Por Huang, C-I, Taki, T, Higashiyama, M, Kohno, N, Miyake, M
Publicado em 2000

Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases.

Por Yokoyama, A, Kohno, N, Hirasawa, Y, Kondo, K, Abe, M, Inoue, Y, Fujioka, S, Fujino, S, Ishida, S, Hiwada, K
Publicado em 1995

Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis

Por Bandoh, S., Fujita, J., Ohtsuki, Y., Ueda, Y., Hojo, S., Tokuda, M., Dobashi, H., Kurata, N., Yoshinouchi, T., Kohno, N., Takahara, J.
Publicado em 2000

Prevention of pneumothorax using venovenous ECMO in acute respiratory distress syndrome with emphysematous/cystic changes in the lung

Por Otani, T, Ohshimo, S, Ota, K, Kida, Y, Inagawa, T, Itai, J, Yamaga, S, Une, K, Iwasaki, Y, Hirohashi, N, Kohno, N, Tanigawa, K
Publicado em 2014

Circulating KL-6 levels in patients with drug induced pneumonitis

Por Ohnishi, H, Yokoyama, A, Yasuhara, Y, Watanabe, A, Naka, T, Hamada, H, Abe, M, Nishimura, K, Higaki, J, Ikezoe, J, Kohno, N
Publicado em 2003

Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast c...

Por Park, Y, Okamura, K, Mitsuyama, S, Saito, T, Koh, J, Kyono, S, Higaki, K, Ogita, M, Asaga, T, Inaji, H, Komichi, H, Kohno, N, Yamazaki, K, Tanaka, F, Ito, T, Nishikawa, H, Osaki, A, Koyama, H, Suzuki, T
Publicado em 2009

Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breas...

Por Park, Y, Okamura, K, Mitsuyama, S, Saito, T, Koh, J, Kyono, S, Higaki, K, Ogita, M, Asaga, T, Inaji, H, Komichi, H, Kohno, N, Yamazaki, K, Tanaka, F, Ito, T, Nishikawa, H, Osaki, A, Koyama, H, Suzuki, T
Publicado em 2009

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials

Por Kroep, J.R., Charehbili, A., Coleman, R.E., Aft, R.L., Hasegawa, Y., Winter, M.C., Weilbaecher, K., Akazawa, K., Hinsley, S., Putter, H., Liefers, G.J., Nortier, J.W.R., Kohno, N.
Publicado no Eur J Cancer (2015)